Journal DOI 10.68956/journal.human-performance-futures

Creative Commons source reading · Machine learning for performance

Artificial intelligence in pituitary surgery: the path to clinical solutions

Hudson G; Khan DZ; Baldeweg SE; Marcus HJ

Originally published in Endocr Relat Cancer · 2026-08-01

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

AbstractArtificial intelligence (AI) is rapidly moving from conceptual innovation to high-performing algorithms across the pituitary patient pathway, promising benefits to patients, endocrinologists and surgeons alike. Pre-operatively, machine learning applied to facial imaging and natural language processing of electronic health records show potential for earlier identification of pituitary adenomas and timelier referral from primary providers to a specialist endocrinologist. Intraoperatively, computer vision systems have already augmented surgical training but have the potential to become integrated real-time decision support systems. Post-operatively, predictive models may help to forecast complications and longer-term remission, endocrinological outcomes or recurrence. Across these domains, the emergence of large, multimodal…

Conclusion

In summary, AI in pituitary patient care has evolved from isolated predictive models into algorithms capable of more appropriately addressing the challenges faced by pituitary patients. While the high accuracy of individual algorithms was previously established, the increasing availability of data has made AI outputs more robust and pipeline architectures have improved their efficiency. There has also been a parallel shift towards technologies designed to integrate with existing workflows. LLMs offer instantaneous decision support, while computer vision can inform operative strategy itself. Post-operatively, predicting sodium imbalances, cure and hypopituitarism has the potential to shape management and follow-up frequency in the community, facilitating more effective use of clinical resources. Despite this progress, AI is scarcely…

Editorial reading guide

  • What data created and tested the model, and was evaluation independent?
  • What is the cost of a false positive, false negative or out-of-distribution decision?